95 related articles for article (PubMed ID: 27704146)
1. First evidence of HERV-H transcriptional activity reduction after methylphenidate treatment in a young boy with ADHD.
D'Agati E; Pitzianti M; Balestrieri E; Matteucci C; Sinibaldi Vallebona P; Pasini A
New Microbiol; 2016 Jul; 39(3):237-239. PubMed ID: 27704146
[TBL] [Abstract][Full Text] [Related]
2. The Decrease in Human Endogenous Retrovirus-H Activity Runs in Parallel with Improvement in ADHD Symptoms in Patients Undergoing Methylphenidate Therapy.
Cipriani C; Pitzianti MB; Matteucci C; D'Agati E; Miele MT; Rapaccini V; Grelli S; Curatolo P; Sinibaldi-Vallebona P; Pasini A; Balestrieri E
Int J Mol Sci; 2018 Oct; 19(11):. PubMed ID: 30360480
[TBL] [Abstract][Full Text] [Related]
3. Human endogenous retroviruses and ADHD.
Balestrieri E; Pitzianti M; Matteucci C; D'Agati E; Sorrentino R; Baratta A; Caterina R; Zenobi R; Curatolo P; Garaci E; Sinibaldi-Vallebona P; Pasini A
World J Biol Psychiatry; 2014 Aug; 15(6):499-504. PubMed ID: 24286278
[TBL] [Abstract][Full Text] [Related]
4. Long-acting methylphenidate reduces collision rates of young adult drivers with attention-deficit/hyperactivity disorder.
Cox DJ; Davis M; Mikami AY; Singh H; Merkel RL; Burket R
J Clin Psychopharmacol; 2012 Apr; 32(2):225-30. PubMed ID: 22367664
[TBL] [Abstract][Full Text] [Related]
5. Association of the adrenergic alpha2A receptor gene with methylphenidate improvement of inattentive symptoms in children and adolescents with attention-deficit/hyperactivity disorder.
Polanczyk G; Zeni C; Genro JP; Guimarães AP; Roman T; Hutz MH; Rohde LA
Arch Gen Psychiatry; 2007 Feb; 64(2):218-24. PubMed ID: 17283289
[TBL] [Abstract][Full Text] [Related]
6. [Efficacy and safety of stimulants and non-stimulants in adults with attention deficit hyperactivity disorder (ADHD)].
Golubchik P; Sever J; Weizman A
Harefuah; 2011 Oct; 150(10):788-90, 814. PubMed ID: 22111124
[TBL] [Abstract][Full Text] [Related]
7. Influence of methylphenidate on spatial attention asymmetry in adolescents with attention deficit hyperactivity disorder (ADHD): preliminary findings.
Silk TJ; Newman DP; Eramudugolla R; Vance A; Bellgrove MA
Neuropsychologia; 2014 Apr; 56():178-83. PubMed ID: 24486422
[TBL] [Abstract][Full Text] [Related]
8. Methylphenidate treatment and dyskinesia in children with attention-deficit/hyperactivity disorder.
Balázs J; Dallos G; Keresztény A; Czobor P; Gádoros J
J Child Adolesc Psychopharmacol; 2011 Apr; 21(2):133-8. PubMed ID: 21486166
[TBL] [Abstract][Full Text] [Related]
9. Gender Differences in the Behavioral Symptoms and Neuropsychological Performance of Patients with Attention-Deficit/Hyperactivity Disorder Treated with Methylphenidate: A Two-Year Follow-up Study.
Wang LJ; Chen CK; Huang YS
J Child Adolesc Psychopharmacol; 2015 Aug; 25(6):501-8. PubMed ID: 26262904
[TBL] [Abstract][Full Text] [Related]
10. Neurocognitive performance and behavioral symptoms in patients with attention-deficit/hyperactivity disorder during twenty-four months of treatment with methylphenidate.
Wang LJ; Chen CK; Huang YS
J Child Adolesc Psychopharmacol; 2015 Apr; 25(3):246-53. PubMed ID: 25574708
[TBL] [Abstract][Full Text] [Related]
11. Megadose intranasal methylphenidate (ritalin) abuse in adult attention deficit hyperactivity disorder.
Coetzee M; Kaminer Y; Morales A
Subst Abus; 2002 Sep; 23(3):165-9. PubMed ID: 12444349
[TBL] [Abstract][Full Text] [Related]
12. An Open-Label, Randomized Trial of Methylphenidate and Atomoxetine Treatment in Children with Attention-Deficit/Hyperactivity Disorder.
Shang CY; Pan YL; Lin HY; Huang LW; Gau SS
J Child Adolesc Psychopharmacol; 2015 Sep; 25(7):566-73. PubMed ID: 26222447
[TBL] [Abstract][Full Text] [Related]
13. Health-related quality of life in methylphenidate-treated children with attention-deficit-hyperactivity disorder: results from a Taiwanese sample.
Yang P; Hsu HY; Chiou SS; Chao MC
Aust N Z J Psychiatry; 2007 Dec; 41(12):998-1004. PubMed ID: 17999272
[TBL] [Abstract][Full Text] [Related]
14. Attention deficit and hyperactivity disorder, methylphenidate, and epilepsy.
Tan M; Appleton R
Arch Dis Child; 2005 Jan; 90(1):57-9. PubMed ID: 15613514
[TBL] [Abstract][Full Text] [Related]
15. Effects of methylphenidate on body index and physical fitness in Korean children with attention deficit hyperactivity disorder.
Kang KD; Yun SW; Chung U; Kim TH; Park JH; Park IH; Han DH
Hum Psychopharmacol; 2016 Mar; 31(2):76-82. PubMed ID: 26756111
[TBL] [Abstract][Full Text] [Related]
16. Attention-deficit/hyperactivity disorder and comorbid subsyndromal depression: what is the impact of methylphenidate on mood?
Golubchik P; Kodesh A; Weizman A
Clin Neuropharmacol; 2013; 36(5):141-5. PubMed ID: 24045603
[TBL] [Abstract][Full Text] [Related]
17. Transition from methylphenidate or amphetamine to atomoxetine in children and adolescents with attention-deficit/hyperactivity disorder--a preliminary tolerability and efficacy study.
Quintana H; Cherlin EA; Duesenberg DA; Bangs ME; Ramsey JL; Feldman PD; Allen AJ; Kelsey DK
Clin Ther; 2007 Jun; 29(6):1168-77. PubMed ID: 17692731
[TBL] [Abstract][Full Text] [Related]
18. MR imaging of the effects of methylphenidate on brain structure and function in attention-deficit/hyperactivity disorder.
Schweren LJ; de Zeeuw P; Durston S
Eur Neuropsychopharmacol; 2013 Oct; 23(10):1151-64. PubMed ID: 23165220
[TBL] [Abstract][Full Text] [Related]
19. [Prescribing ritalin in combined modality management of hyperactivity with attention deficit].
Bricard C; Boidein F
Encephale; 2001; 27(5):435-43. PubMed ID: 11760693
[TBL] [Abstract][Full Text] [Related]
20. Common and unique therapeutic mechanisms of stimulant and nonstimulant treatments for attention-deficit/hyperactivity disorder.
Schulz KP; Fan J; Bédard AC; Clerkin SM; Ivanov I; Tang CY; Halperin JM; Newcorn JH
Arch Gen Psychiatry; 2012 Sep; 69(9):952-61. PubMed ID: 22945622
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
